Breaking News

You are here » Indian-Commodity  :  IPO  :  IndoStar Capital Finance gets SEBI's nod to float IPO

10-Apr2018

IndoStar Capital Finance gets SEBI's nod to float IPO

IndoStar Capital Finance has received markets regulator Securities and Exchange Board of India's (SEBI) approval to raise funds worth Rs 2,000 crore through an initial public offering (IPO). The IPO comprises issuance of fresh shares worth Rs 700 crore. Besides, existing shareholders will offer up to 2 crore shares.

The company plans to utilize the net proceeds from the fresh issue towards augmenting its capital base to meet future capital requirements. The IPO will also enhance its brand name and create public market for its equity shares in the country.

JM Financial, Kotak Mahindra Capital Company, Morgan Stanley India Company, Motilal Oswal Investment Advisors and Nomura Financial Advisory and Securities (India) will manage the public issue.

IndoStar Capital Finance is a non-banking finance company 'NBFC' registered with the Reserve Bank of India as a systemically important non-deposit taking company.


Related News

View all news

Spandana Sphoorty gets SEBI's nod for IPO

Spandana Sphoorty Financial has received markets regulator Securities and Exchange Board of India's (SEBI) approval to raise funds through an initial public offering (IPO). The IPO consists of fresh issue......

Bharat Hotels gets SEBI's approval for IPO

Bharat Hotels has received markets regulator Securities and Exchange Board of India's (SEBI) approval to raise funds through an initial public offering (IPO). The IPO comprises sale of fresh equity shares......

Chartered Speed files DRHP with SEBI for public issue

Fleet bus operators Chartered Speed has filed draft red herring prospectus (DRHP) with the market regulator Securities and Exchange Board of India (SEBI) to raise an estimated Rs 273 crore through an Initial......

Top News

View all news

Zydus Cadila gets USFDA's approval for Nystatin and Triamcinolone Acetonide Ointment

Zydus Cadila has received the final approval from the United States Food and Drug Administration (USFDA) to market Nystatin and Triamcinolone Acetonide Ointment USP, (US RLD -Mycolog-II Ointment), 100,000......

Tata Steel flags-off Art Residency Programme at CFE Jamshedpur

Tata Steel has flagged off the first-ever Art Residency Programme in Jamshedpur under the aegis of the Centre for Excellence (CFE) Jamshedpur.The 12-day Art Residency aims to offer a platform for artistic......

Sobha reports 22% rise in Q2 consolidated net profit

Sobha has reported results for second quarter ended September 30, 2018.The company has reported a rise of 28.76% in its net profit at Rs 57.30 crore for the quarter under review as compared to Rs 44.50......